University of California San Francisco

Robert Jaffe, MD

August 18, 2019

Robert Jaffe, MDUniversity of California San Francisco Inhibition of Telomerase to Treat Advanced Ovarian Cancer Telomerase is an enzyme that maintains and protects the ends of chromosomes, the telomeres. While telomerase is constrained in many normal adult cells, a majority of cancers appear to depend on active telomerase for their growth, making this enzyme an […]

Read More

Heike Daldrup-Link, MD, PhD

August 18, 2019

Heike Daldrup-Link, MD, PhDUniversity of California, San Francisco MR imaging of ovarian cancer with folate-receptor targeted contrast agents Folate-receptors are relatively absent in normal tissues but overexpressed on cancer cells. Therefore, folate-receptor targeted contrast agents have the potential to provide cancer specific imaging. By targeting these receptors so they will appear vividly in magnetic resonance […]

Read More